Correction to: Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD.

Journal

Molecular neurodegeneration
ISSN: 1750-1326
Titre abrégé: Mol Neurodegener
Pays: England
ID NLM: 101266600

Informations de publication

Date de publication:
01 07 2020
Historique:
entrez: 3 7 2020
pubmed: 3 7 2020
medline: 3 7 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via the original article.

Identifiants

DOI: 10.1186/s13024-020-00390-8 PMID: 32611370 PMC: PMC7330954
pubmed: 32611370
doi: 10.1186/s13024-020-00390-8
pii: 10.1186/s13024-020-00390-8
pmc: PMC7330954
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Commentaires et corrections

Type : ErratumFor

Références

Mol Neurodegener. 2020 Jun 8;15(1):34
pubmed: 32513219

Auteurs

Xiaoqiang Tang (X)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

Arturo Toro (A)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

T G Sahana (TG)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

Junli Gao (J)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

Jessica Chalk (J)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

Björn Oskarsson (B)

Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.

Ke Zhang (K)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. zhang.ke@mayo.edu.
Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, USA. zhang.ke@mayo.edu.

Classifications MeSH